Literature DB >> 25577461

Noninvasive embryo viability assessment by quantitation of human haptoglobin alpha-1 fragment in the in vitro fertilization culture medium: an additional tool to increase success rate.

Gergely Montskó1, Zita Zrínyi1, Tamás Janáky2, Zoltán Szabó2, Ákos Várnagy3, Gábor L Kovács4, József Bódis5.   

Abstract

OBJECTIVE: To find new candidate molecules to assess embryo viability in a noninvasive manner.
DESIGN: Prospective, blinded study with randomized sample collection.
SETTING: University research center. PATIENTS(S): Ninety embryos implanted in 53 randomly selected patients (mean ± SD age, 32.3 ± 5.1 years) were analyzed. INTERVENTION(S): Superovulation treatment was initiated by the administration of the GnRh agonist triptorelin and individual dosages of recombinant FSH. Ovulation was induced by the injection of hCG. Oocytes were fertilized by intracytoplasmic sperm injection. MAIN OUTCOME MEASURE(S): Liquid chromatography coupled mass spectrometric quantification of the α-1 fragment of human haptoglobin in the culture medium. RESULT(S): A novel polypeptide marker was found that might be helpful to differentiate between potentially viable and nonviable embryos. This molecule was identified with tandem mass spectrometry as the α-1 fragment of human haptoglobin. Significant correlation was found in the amount of the peptide fragment and the outcome of pregnancy. In the culture media of embryos that were assigned in the biochemical assay as nonviable (according to the amount of the haptoglobin fragment), there were no pregnancies detected; this assay revealed a 100% successful selection of the nonviable embryos. In the group assigned as viable, the rate of pregnancy was 54.7%. CONCLUSION(S): Viability of the embryo during the IVF process is assessed by microscopic inspection, resulting in a pregnancy rate of 25%-30%. Detection and quantitation of the α-1 haptoglobin fragment of the culture medium proved to be a useful additional method for identifying nonviable embryos, increasing the success rate to 50%.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  In vitro fertilization; biomarker; embryo viability; mass spectrometry

Mesh:

Substances:

Year:  2015        PMID: 25577461     DOI: 10.1016/j.fertnstert.2014.11.031

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  GDF9 concentration in embryo culture medium is linked to human embryo quality and viability.

Authors:  Jingyu Li; Chong Li; Xuemei Liu; Jingwei Yang; Qi Zhang; Wei Han; Guoning Huang
Journal:  J Assist Reprod Genet       Date:  2021-11-29       Impact factor: 3.412

Review 2.  Implementing a preimplantation proteomic approach to advance assisted reproduction technologies in the framework of predictive, preventive, and personalized medicine.

Authors:  Vasiliki Kanaka; Stavros Proikakis; Petros Drakakis; Dimitrios Loutradis; George Th Tsangaris
Journal:  EPMA J       Date:  2022-05-21       Impact factor: 8.836

Review 3.  Non-invasive methods for embryo selection.

Authors:  H N Sallam; N H Sallam; S H Sallam
Journal:  Facts Views Vis Obgyn       Date:  2016-06-27

4.  Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization.

Authors:  Sylvie Bouvier; Odile Paulmyer-Lacroix; Nicolas Molinari; Alexandrine Bertaud; Marine Paci; Aurélie Leroyer; Stéphane Robert; Françoise Dignat George; Marcel Blot-Chabaud; Nathalie Bardin
Journal:  PLoS One       Date:  2017-03-14       Impact factor: 3.240

5.  A simple and rapid flow cytometry-based assay to identify a competent embryo prior to embryo transfer.

Authors:  Eva Pallinger; Zoltan Bognar; Jozsef Bodis; Timea Csabai; Nelli Farkas; Krisztina Godony; Akos Varnagy; Edit Buzas; Julia Szekeres-Bartho
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

6.  NGS-Based Application for Routine Non-Invasive Pre-Implantation Genetic Assessment in IVF.

Authors:  Katalin Gombos; Bence Gálik; Krisztina Ildikó Kalács; Krisztina Gödöny; Ákos Várnagy; Donát Alpár; József Bódis; Attila Gyenesei; Gábor L Kovács
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

Review 7.  Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies.

Authors:  Charalampos S Siristatidis; Eleni Sertedaki; Dennis Vaidakis; Christos Varounis; Marialena Trivella
Journal:  Cochrane Database Syst Rev       Date:  2018-03-16

8.  Non-Invasive Assessment of Viability in Human Embryos Fertilized in Vitro.

Authors:  Gábor L Kovács; Gergely Montskó; Zita Zrínyi; Nelli Farkas; Ákos Várnagy; József Bódis
Journal:  EJIFCC       Date:  2016-04-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.